News
Landmark Sickle Cell Disease Trial
| Landmark Sickle Cell Disease Trial |
|
|
Landmark Sickle Cell Disease Trial To Investigate Unrelated Donor Marrow And Umbilical Cord Blood TransplantsChildren's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease. Children's National will join more than 20 other medical institutions in the first-ever Phase II clinical trial of this treatment. If successful, the Sickle Cell Unrelated Transplant (SCURT) trial has the potential to extend a promising and possibly curative treatment option to more severely affected patients. Sickle cell disease affects approximately 70,000 people in the United States. To read the full story, as reported in Science Daily, please click here |
| < Prev | Next > |
|---|
Through this website you are able to link to other websites which are not under the control of Smart Cells International. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.






